SRPK2 and cancer: One of the important findings of our study was the ability of the small molecule inhibitors to more efficiently inhibit the activities of CLK1/CLK2 compared with those of SRPK1/SRPK2, which was significantly correlated with the splicing alterations of S6K pre-mRNA as well as the inhibition of cancer cell growth.